Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

Cytoprotective effect of Valeriana officinalis extract on an in vitro experimental model of Parkinson disease.

de Oliveria DM, Barreto G, De Andrade DV, Saraceno E, Aon-Bertolino L, Capani F, Dos Santos El Bachá R, Giraldez LD.

Neurochem Res. 2009 Feb;34(2):215-20. doi: 10.1007/s11064-008-9749-y. Epub 2008 May 30.

PMID:
18512151
2.

Effects of the extract of Anemopaegma mirandum (Catuaba) on Rotenone-induced apoptosis in human neuroblastomas SH-SY5Y cells.

Valverde G De Andrade D, Madureira de Oliveria D, Barreto G, Bertolino LA, Saraceno E, Capani F, Giraldez LD.

Brain Res. 2008 Mar 10;1198:188-96. doi: 10.1016/j.brainres.2008.01.006. Epub 2008 Jan 14.

PMID:
18241847
3.

Valeriana officinalis attenuates the rotenone-induced toxicity in Drosophila melanogaster.

Sudati JH, Vieira FA, Pavin SS, Dias GR, Seeger RL, Golombieski R, Athayde ML, Soares FA, Rocha JB, Barbosa NV.

Neurotoxicology. 2013 Jul;37:118-26. doi: 10.1016/j.neuro.2013.04.006. Epub 2013 Apr 29.

4.

Paullinia cupana Mart. var. Sorbilis protects human dopaminergic neuroblastoma SH-SY5Y cell line against rotenone-induced cytotoxicity.

de Oliveira DM, Barreto G, Galeano P, Romero JI, Holubiec MI, Badorrey MS, Capani F, Alvarez LD.

Hum Exp Toxicol. 2011 Sep;30(9):1382-91. doi: 10.1177/0960327110389837. Epub 2010 Nov 16.

PMID:
21081703
5.

Edible bird's nest ameliorates oxidative stress-induced apoptosis in SH-SY5Y human neuroblastoma cells.

Yew MY, Koh RY, Chye SM, Othman I, Ng KY.

BMC Complement Altern Med. 2014 Oct 13;14:391. doi: 10.1186/1472-6882-14-391.

6.

Leaf extract of Rhus verniciflua Stokes protects dopaminergic neuronal cells in a rotenone model of Parkinson's disease.

Kim S, Park SE, Sapkota K, Kim MK, Kim SJ.

J Pharm Pharmacol. 2011 Oct;63(10):1358-67. doi: 10.1111/j.2042-7158.2011.01342.x. Epub 2011 Aug 30.

PMID:
21899552
7.

SUR1 Receptor Interaction with Hesperidin and Linarin Predicts Possible Mechanisms of Action of Valeriana officinalis in Parkinson.

Santos G, Giraldez-Alvarez LD, Ávila-Rodriguez M, Capani F, Galembeck E, Neto AG, Barreto GE, Andrade B.

Front Aging Neurosci. 2016 May 2;8:97. doi: 10.3389/fnagi.2016.00097. eCollection 2016.

8.

Extract of valerian root (Valeriana officinalis L.) vs. placebo in treatment of obsessive-compulsive disorder: a randomized double-blind study.

Pakseresht S, Boostani H, Sayyah M.

J Complement Integr Med. 2011 Oct 11;8. pii: /j/jcim.2011.8.issue-1/1553-3840.1465/1553-3840.1465.xml. doi: 10.2202/1553-3840.1465.

PMID:
22718671
9.

Valeriana officinalis root extracts have potent anxiolytic effects in laboratory rats.

Murphy K, Kubin ZJ, Shepherd JN, Ettinger RH.

Phytomedicine. 2010 Jul;17(8-9):674-8. doi: 10.1016/j.phymed.2009.10.020. Epub 2009 Dec 29.

PMID:
20042323
10.

Neuroprotective effect of Demethoxycurcumin, a natural derivative of Curcumin on rotenone induced neurotoxicity in SH-SY 5Y Neuroblastoma cells.

Ramkumar M, Rajasankar S, Gobi VV, Dhanalakshmi C, Manivasagam T, Justin Thenmozhi A, Essa MM, Kalandar A, Chidambaram R.

BMC Complement Altern Med. 2017 Apr 18;17(1):217. doi: 10.1186/s12906-017-1720-5.

11.

Anticonvulsant effect of aqueous extract of Valeriana officinalis in amygdala-kindled rats: possible involvement of adenosine.

Rezvani ME, Roohbakhsh A, Allahtavakoli M, Shamsizadeh A.

J Ethnopharmacol. 2010 Feb 3;127(2):313-8. doi: 10.1016/j.jep.2009.11.002. Epub 2009 Nov 10.

PMID:
19900527
12.

Valerenic acid and Valeriana officinalis extracts delay onset of Pentylenetetrazole (PTZ)-Induced seizures in adult Danio rerio (Zebrafish).

Torres-Hernández BA, Del Valle-Mojica LM, Ortíz JG.

BMC Complement Altern Med. 2015 Jul 14;15:228. doi: 10.1186/s12906-015-0731-3.

13.

The estrogen receptor β-PI3K/Akt pathway mediates the cytoprotective effects of tocotrienol in a cellular Parkinson's disease model.

Nakaso K, Tajima N, Horikoshi Y, Nakasone M, Hanaki T, Kamizaki K, Matsura T.

Biochim Biophys Acta. 2014 Sep;1842(9):1303-12. doi: 10.1016/j.bbadis.2014.04.008. Epub 2014 Apr 24.

14.

Extracts of Valeriana officinalis L. s.l. show anxiolytic and antidepressant effects but neither sedative nor myorelaxant properties.

Hattesohl M, Feistel B, Sievers H, Lehnfeld R, Hegger M, Winterhoff H.

Phytomedicine. 2008 Jan;15(1-2):2-15.

PMID:
18160026
15.

Relaxing effects of Valeriana officinalis extracts on isolated human non-pregnant uterine muscle.

Occhiuto F, Pino A, Palumbo DR, Samperi S, De Pasquale R, Sturlese E, Circosta C.

J Pharm Pharmacol. 2009 Feb;61(2):251-6. doi: 10.1211/jpp/61.02.0016.

PMID:
19178774
16.

Polysomnographic evaluation of the hypnotic effect of Valeriana edulis standardized extract in patients suffering from insomnia.

Herrera-Arellano A, Luna-Villegas G, Cuevas-Uriostegui ML, Alvarez L, Vargas-Pineda G, Zamilpa-Alvarez A, Tortoriello J.

Planta Med. 2001 Nov;67(8):695-9.

PMID:
11731907
17.

Valeriana officinalis extract and its main component, valerenic acid, ameliorate D-galactose-induced reductions in memory, cell proliferation, and neuroblast differentiation by reducing corticosterone levels and lipid peroxidation.

Nam SM, Choi JH, Yoo DY, Kim W, Jung HY, Kim JW, Kang SY, Park J, Kim DW, Kim WJ, Yoon YS, Hwang IK.

Exp Gerontol. 2013 Nov;48(11):1369-77. doi: 10.1016/j.exger.2013.09.002. Epub 2013 Sep 18.

PMID:
24055511
18.

The influence of standardized Valeriana officinalis extract on the CYP3A1 gene expression by nuclear receptors in in vivo model.

Bogacz A, Mrozikiewicz PM, Karasiewicz M, Bartkowiak-Wieczorek J, Majchrzycki M, Mikolajczak PL, Ozarowski M, Grzeskowiak E.

Biomed Res Int. 2014;2014:819093. doi: 10.1155/2014/819093. Epub 2014 Sep 11.

19.

Neuroprotective effect of Rosmarinus officinalis extract on human dopaminergic cell line, SH-SY5Y.

Park SE, Kim S, Sapkota K, Kim SJ.

Cell Mol Neurobiol. 2010 Jul;30(5):759-67. doi: 10.1007/s10571-010-9502-3. Epub 2010 Feb 21.

PMID:
20563702
20.

Supplemental Content

Support Center